The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of pSTAT5 gene signature in hematologic malignancy.
Dmitriy Sonkin
Employment or Leadership Position - Novartis
Catherine Regnier
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Xianhui Rong
Employment or Leadership Position - Novartis (I); Novartis
Christie Fanton
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Michael Palmer
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jocelyn Holash
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Matthew Squires
Employment or Leadership Position - Novartis
L. Andres Sirulnik
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Thomas Radimerski
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Robert Schlegel
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Michael Morrissey
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Z, Alexander Cao
Employment or Leadership Position - Novartis (I); Novartis
Stock Ownership - Novartis